Effect of diabetes on islet area and beta-cell function.
V. Bonnevie‐Nielsen, Åke Lernmark
Abstract
V. Bonnevie‐Nielsen, Åke Lernmark
Abstract
beta-cell function was studied in the isolated perfused mouse pancreas. Morphometrical analysis of the islets of Langerhans was done after in situ staining with dithizone. Islet area correlated well with the fasted body weight. Fasting hyperglycemia was induced 15 days after the start of a daily injection of streptozotocin (40 mg/kg) for 5 days. At day 15 the total islet area was reduced to 1% and total insulin release to 4% of the controls. The presence of fasting hyperglycemia in mice after low-dose streptozotocin treatment is associated with a major loss in beta-cell function and islet mass.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
beta-cell function was studied in the isolated perfused mouse pancreas. Morphometrical analysis of the islets of Langerhans was done after in situ staining with dithizone. Islet area correlated well with the fasted body weight. Fasting hyperglycemia was induced 15 days after the start of a daily injection of streptozotocin (40 mg/kg) for 5 days. At day 15 the total islet area was reduced to 1% and total insulin release to 4% of the controls. The presence of fasting hyperglycemia in mice after low-dose streptozotocin treatment is associated with a major loss in beta-cell function and islet mass.
Key concepts: Islet, Streptozotocin, Endocrinology, Internal medicine, Beta cell, Pancreas, Diabetes mellitus, BETA (programming language)